Specialised Therapeutics Australia has become the exclusive distributor in ANZ for Iluvien, a DMO treatment being commercialised by Alimera Sciences under licence from pSivida (ASX:PVA). [ + ]

Lonza Bioscience Singapore has received cGMP certification from the Singapore Health Sciences Authority (HSA) for its cell-therapy manufacturing facility, while Lonza Group has announced changes in the composition of its executive committee (EC). [ + ]

The 2014 BioBusiness Asia Conference, this year combined with BioTaiwan Exhibition 2014 to enlarge the partnering candidate pool, is calling for proposals from companies interested in presenting. [ + ]

Prima BioMed (ASX:PRR) has signed up the first patient for CAN-004, its phase II trial of therapy candidate CVac in epithelial ovarian cancer. [ + ]

Haplomic Technologies has picked up patents in the EU and the US for its core IP, which covers genetic sequencing technologies based on haplotypes. [ + ]

A comparison of Y chromosome sequences across various mammals has revealed new gene repertoires for the major groups. [ + ]

US research firm The Freedonia Group has released the report 'Excipients', an industry study showcasing trends and forecasts in the pharmaceutical excipients market. The study also analyses market environment factors, evaluates company market share and profiles 47 US industry competitors. [ + ]

Cell Therapies has selected Dr Tim Oldham to become its new CEO to help drive the company's South-East Asian growth strategy. [ + ]

Therapeutic antibody supplier MorphoSys and technology company Biametrics will continue their collaboration in the area of high-throughput antibody screening following a successful feasibility study. [ + ]

Phosphagenics has completed enrolment for a phase II trial of an acne treatment candidate that uses its TPM transdermal drug delivery technology. [ + ]

The most comprehensive export survey of its type, Australia's International Business Survey, was conducted to understand and highlight the major issues facing exporters. [ + ]

Scientia Professor of Physics Michelle Simmons, from the University of New South Wales (UNSW), has been elected as a foreign honorary member of the American Academy of Arts and Sciences. She is one of only 10 Australians to have received such an honour. [ + ]

Monash University has been awarded almost $10 million to develop new treatments for life-threatening infections caused by antibiotic-resistant bacteria. [ + ]

Analytica (ASX:ALT) is raising up to $3m through a placement and entitlement offer to help accelerate its marketing efforts for female urinary incontinence treatment device PeriCoach. [ + ]

Research led by the University of New South Wales (UNSW) has found that the bacterium that causes whooping cough, Bordetella pertussis, has changed - most likely in response to the vaccine used to prevent the disease. [ + ]